Medical News

RSS

Orion extends use of Medidata Rave enterprise-wide EDC and clinical data management system

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that European pharmaceutical company Orion has extended its use of Medidata Rave® as its enterprise-wide electronic data capture (EDC) and clinical data management (CDM) system, which Orion successfully brought in-house and deployed for all clinical trials for the past three and a half years.

13 Sep 2010

Defibtech receives Health Canada approval for Lifeline View AED device

Defibtech, LLC, a leading innovator in the Automated External Defibrillation (AED) market, today announced that it has received approval from Health Canada to market the Lifeline View™ AED device. The Lifeline View AED is the first and only AED to offer a full-color interactive display that shows users step-by-step how to perform CPR and external defibrillation.

13 Sep 2010

NIH awards PhysioNetics $815,000 for development of low-cost prosthetic interface

ADA Technologies, Inc.'s PhysioNetics division has been awarded an $815,000 grant from the National Institutes of Health, National Institute of Child Health and Human Development. The Phase II award will enable PhysioNetics to complete design refinements and commercialization activities for its low-cost upper-extremity prosthetic interface, also known as a "socket."

13 Sep 2010

Synta expands STA-9090 Phase 2 clinical trial in NSCLC

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it was expanding its Phase 2 clinical trial of STA-9090 in patients with Stage IIIB and Stage IV non-small cell lung cancer (NSCLC) from up to 69 patients to up to 146 patients based on encouraging activity observed in the first stage of the two stage clinical trial.

13 Sep 2010

Relypsa completes $70M Series B financing

Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced the completion of a Series B financing totaling $70 million. OrbiMed Advisors, LLC, led the financing with participation from existing Relypsa investors New Leaf Venture Partners, 5AM Ventures, Delphi Ventures, Sprout Group and Mediphase Venture Partners.

13 Sep 2010

U-Systems granted EU marketing approval for somo•v Automated Breast Ultrasound system

U-Systems, the leader in automated breast ultrasound, today announced that it has received approval to market the somo•v™ Automated Breast Ultrasound (ABUS) system as an adjunct to mammography for screening asymptomatic women for breast cancer in the European Union.

13 Sep 2010

Cytori Therapeutics releases schedule of fall 2010 and investor conferences

Cytori Therapeutics announced today its fall 2010 conference schedule.

13 Sep 2010

American Cancer Society announces details of new campaign

The American Cancer Society, the official sponsor of birthdays, today announced details of a unique new campaign that marks the next phase of the Society's movement for More Birthdays. Over the past several months, dozens of the biggest names in music and art have come together, inspired by the efforts of the American Cancer Society, its supporters and everyone affected by cancer, to generously donate their talent and artwork to help amplify the voice of the More Birthdays movement.

13 Sep 2010

Keais Records Service launches new online portal

Keais Records Service, established in 1975 as the first litigation support company specializing in records retrieval services, is celebrating its milestone thirty-fifth anniversary by launching a new web site and further enhancing its electronic capabilities to serve the litigation discovery needs of major law firms, insurance companies, corporations and TPAs.

13 Sep 2010

Better Living Health and Community Services hosts forum to discuss issues that matter most to seniors

Better Living Health and Community Services is hosting a moderated forum for the frontrunners for Toronto's mayoralty to discuss the issues that matter most to seniors.

13 Sep 2010

Genoptix to participate 2010 UBS Global Life Sciences Conference

Genoptix, Inc., a specialized laboratory services provider, today announced the Company's participation at the 2010 UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York City, to be held September 20-22, 2010.

13 Sep 2010

UnitedHealth Group attains highest total Index score in Healthcare Provider Sector

UnitedHealth Group today announced that the company has been named to both the Dow Jones Sustainability North America Index and the Dow Jones Sustainability World Index. UnitedHealth Group attained the highest total Index score in the Healthcare Provider Sector, and was a leader among peer companies worldwide in corporate governance, service to patients, partnerships toward sustainable health care, stakeholder engagement, and corporate citizenship and philanthropy.

13 Sep 2010

FDA updates Shire's ProAmatine medicine for symptomatic orthostatic hypotension treatment

Shire, the global specialty biopharmaceutical company, announces that the United States Food and Drug Administration today posted an update on its website related to ProAmatine (known generically as midodrine), a medicine approved for the treatment of symptomatic orthostatic hypotension.

13 Sep 2010

Regis to kick off Clip for the Cure campaign to raise money, awareness for breast cancer research

In October, Regis Corporation, the global leader in the haircare industry, will kick off its annual Clip for the Cure, a month-long campaign to raise money and awareness for breast cancer research in support of National Breast Cancer Awareness Month. To date, the company's dedicated stylists and clients have raised more than $6.5 million for the cause.

13 Sep 2010

Geron, UCS collaborate to develop hESC-derived chondrocytes for cartilage damage, joint disease treatment

Geron Corporation today announced that the company has entered into a collaboration with University Campus Suffolk (UCS) in the U.K. to develop human embryonic stem cell-derived chondrocytes for the treatment of cartilage damage and joint disease.

13 Sep 2010

SPADnet to develop CMOS image sensors for photon-starved biomedical applications

SPADnet aims to develop a new generation of smart, CMOS-based large area networked image sensors for photon-starved biomedical applications. "Fully Networked, Digital Components for Photon-starved Biomedical Imaging Systems" - is a new collaborative research project funded by the European Union within the Information and Communication Technologies (ICT) Theme of its Seventh Research Framework Programme (FP7).

13 Sep 2010

Positron announces opening of Clinical and Technical Cardiovascular PET Training Institute

Positron Corporation, a molecular imaging company specializing in Nuclear Cardiology and a leader in Cardiac PET, announced today the grand opening of its Clinical and Technical Cardiovascular PET Training Institute in Niagara Falls, NY.

13 Sep 2010

Jennerex reports positive interim data from trial of JX-594 and sorafenib for liver cancer

Jennerex, Inc., a clinical-stage biotherapeutics company focused on the development of first-in-class, targeted oncolytic products for cancer, today reported positive interim data from a pilot trial using JX-594 followed by sorafenib (Nexavar®) to treat liver cancer patients. The data were presented today at the Fourth Annual International Liver Cancer Association Conference in Montreal, Canada.

13 Sep 2010

AB SCIEX, University of Melbourne join to develop drug metabolism studies of biopharmaceuticals

AB SCIEX, a global leader in life science analytical technologies, and the University of Melbourne today announced a joint technology development project to improve drug metabolism studies of biopharmaceuticals.

13 Sep 2010

InterMune's development program for pirfenidone, IPF to be presented at Annual Congress of ERS

InterMune, Inc. today announced that four oral presentations related to the company's development program for pirfenidone and idiopathic pulmonary fibrosis will be presented at the Annual Congress of the European Respiratory Society, to be held September 18-22 in Barcelona, Spain.

13 Sep 2010

Medical News

Orion extends use of Medidata Rave enterprise-wide EDC and clinical data management system

Defibtech receives Health Canada approval for Lifeline View AED device

NIH awards PhysioNetics $815,000 for development of low-cost prosthetic interface

Synta expands STA-9090 Phase 2 clinical trial in NSCLC

Relypsa completes $70M Series B financing

U-Systems granted EU marketing approval for somo•v Automated Breast Ultrasound system

Cytori Therapeutics releases schedule of fall 2010 and investor conferences

American Cancer Society announces details of new campaign

Keais Records Service launches new online portal

Better Living Health and Community Services hosts forum to discuss issues that matter most to seniors

Genoptix to participate 2010 UBS Global Life Sciences Conference

UnitedHealth Group attains highest total Index score in Healthcare Provider Sector

FDA updates Shire's ProAmatine medicine for symptomatic orthostatic hypotension treatment

Regis to kick off Clip for the Cure campaign to raise money, awareness for breast cancer research

Geron, UCS collaborate to develop hESC-derived chondrocytes for cartilage damage, joint disease treatment

SPADnet to develop CMOS image sensors for photon-starved biomedical applications

Positron announces opening of Clinical and Technical Cardiovascular PET Training Institute

Jennerex reports positive interim data from trial of JX-594 and sorafenib for liver cancer

AB SCIEX, University of Melbourne join to develop drug metabolism studies of biopharmaceuticals

InterMune's development program for pirfenidone, IPF to be presented at Annual Congress of ERS

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News